Cyclopharm Ltd has released a press release.
Announcement of buy-back - Appendix 3C
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Cyclopharm
- CYC Update - R&D Tax Incentive, USFDA, German Litigation
- CANM Endorses Technegas
- Positive USFDA Meeting - Technegas sales expected in 2019
- Cyclopharm 2018 First Half Preliminary Headline Update
- CYC 2018 AGM Presentation
Later from Cyclopharm
- CYC Half Yearly Reports and Accounts
- CYC Business Update
- Pause in Trading
- Agreement to utilise cyclotron facility assets
- CYC Institutional Placement - Premium To Share Price
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm